Michael Engsig

[Michael Engsig @MEngsig]

@cantargia Great job guys 👍👍

[Michael Engsig @MEngsig]

@fornybarbio Bestemt

[Michael Engsig @MEngsig]

https://t.co/IxLYhmuAl4

[Michael Engsig @MEngsig]

🤔
Israeli panel recommends fourth Covid vaccine dose for all adults https://t.co/pYPCM6DQ8G

[Michael Engsig @MEngsig]

This is so true. Much work ahead of us. Clear words in this short opinion. COVID-19: endemic doesn’t mean harmless https://t.co/56j3xGoCoL

[Dr Kevin Purcell @kevinpurcell.bsky.social @kevinpurcell]

In week 50 BA.2 was 2% in Denmark.

“That number has now risen to 28% in Week 1.”

“At the same time, the proportion of cases of BA1 has dropped from 72% to 68%. The last 4% is made up of the delta variant.”

Interestingly, Delta hung on in DK in early ‘22 https://t.co/yzJ1xAel3h

[Eric Topol @EricTopol]

It's very hard to watch today as the US hospitalizations climbed above 150,000, ICUs more than 25,000, and nearly 2,700 deaths—the vast majority were preventable by vaccinations and/or boosters.
And >900,000 new cases, some of whom will progress to severe disease or #LongCovid

[Adaptive Biotech @AdaptiveBiotech]

Nykode CEO @MEngsig and CISO @ABFredriksen present an update on its next-gen COVID-19 vaccine candidates, including a T-cell-based vaccine developed using epitopes identified and validated by our immune medicine platform. Watch now at https://t.co/uZ80pYGhxT.

[Adaptive Biotech @AdaptiveBiotech]

T-cell-based vaccines have the potential to elicit a broad and durable immune response to SARS-CoV-2 including Omicron and future variants. Learn more about our collaboration with Nykode Therapeutics on next-gen COVID-19 vaccines at https://t.co/SQxPC9dpb0.

@ABFredriksen

[Lucy Thorne @lucygthorne]

Excited to finally share our SARS-CoV-2 paper in @Nature !! 🙌 Have learnt so much being part of this amazing team @akreuschl @LorenaZAlvarez @DoctorBou @towerslab @Jolly_lab @KroganLab @matthewVXwhelan @igoodfel & many more https://t.co/FsyXk7OxLR here’s what we found 👇

[Michael Engsig @MEngsig]

@EricTopol @Annals_Oncology @DrChoueiri @NatureCancer @EricTopol it’s the first line with vaccinated vs unvaccinated that really starts concerning me. Thoughts please.
Please also look at the Danish distributions of vaccinated vs unvaccinated infected with omicron vs delta. 🙏

[Michael Engsig @MEngsig]

@EricTopol In Denmark I’m afraid it’s just because all the healthy folks test before seeing their relatives. I’m not convinced yet this is a true downward trend.

[Bob Wachter @Bob_Wachter]

Anybody who says "I hate Twitter" has never tried to keep up with a pandemic in which crucial new data is released every few hours, data that often requires sophisticated interpretation by domain experts in areas ranging from virology to epidemiology to supply chain to sociology.

[Michael Engsig @MEngsig]

Amongst God knows what wave and Omicron - it looks like White Christmas in Copenhagen. Happy holidays to all 🎉⭐️ @ Kongens Lyngby https://t.co/IuqONGmOxP

[Florian Krammer @florian_krammer]

First look at Omicron neutralization from @sigallab. That is a huge drop.

[Tom Wenseleers now @twenseleers.bsky.social @TWenseleers]

A short thread with some thoughts & calculations of mine about Omicron. Still preliminary, so don't take any figures as final, but it's a start... 🧵

[Eric Topol @EricTopol]

From Omicron's sequence, there's a lot of antigenic drift, posing the threat of evading our immune response. Good that vaccine companies are gearing up for it. But we ought to be pressing hard for a pan-sarbecovirus vaccine that would target *all* variants https://t.co/avBeceJvox

[Michael Engsig @MEngsig]

@LadyBorup Lidt på linje med “der laves også god pinot noir uden for Bourgogne”

[Michael Engsig @MEngsig]

@sorenpind @carlbildt Det er for vildt Søren. Med mindre du er sarkastisk. Læg skovlen og gå væk fra hullet.

[Michael Engsig @MEngsig]

@troelsj @borsendk Det er vel både en trist tilstand i riget og en uheldig overskrift.